Chardan Capital Has Negative Outlook of COYA FY2025 Earnings
Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Investment analysts at Chardan Capital reduced their FY2025 earnings per share (EPS) estimates for shares of Coya Therapeutics in a report released on Wednesday, May 14th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings of ($1.57) per share for the year, down […]
More Stories
Monthly Payments for Homes Increased 1st Time in 6 Months
By Naveen Athrappully The median monthly mortgage payment in the United States hit $2,742 for the four weeks ending March...
Trump’s 3D Chess: How President Trump Is Checkmating China and Russia by Toppling Their Oil Proxies in Venezuela, Cuba, and Iran
By Stephen Zogopoulos, USNN World News In the rarefied world of grand strategy, true masters don’t play on a flat...
Iran Vows Lasting Grip on Strait of Hormuz After War
By Tom Ozimek Iran has signaled that it intends to exert lasting control over the Strait of Hormuz—the world’s most...
Trump Signs Memo to Pay All DHS Employees During Shutdown
By Troy Myers President Donald Trump on Friday signed a memorandum directing the Department of Homeland Security (DHS) to pay...
Best Photo Editing Apps in 2026: Features, Pricing, and Limitations
Finding the best photo editing app in 2026 has become difficult. With several Android and iOS editing tools available in...
In the Mud Season 3: Release Date, Cast, Trailer, and Spoiler
If you have already watched the first two seasons of In the Mud, then you must also be curious about...